Villich News

AstraZeneca rushes immuno-oncology star into PhIII lung cancer study


Fierce Biotech - 09-May-2014

Anxious to fight off Pfizer's $106 billion marriage proposal, AstraZeneca's research team has rushed its high-profile immuno-oncology drug into a late-stage test. And they're setting out by targeting non-small cell lung cancer in the first Phase III in the MEDI4736 program. ...


Read full article at Fierce Biotech


The Wall Street Journal - 26-Sep-2014

The craft of opposition research—finding information that might put an opponent in a negative light—has long been a staple of political campaigns. This year, independent groups are taking a leading role....

The Wall Street Journal - 26-Sep-2014

Cynthia Quarterman, a top U.S. safety regulator tasked with handling the U.S. government's response to a string of oil-train crashes in recent years, is stepping down....

The Wall Street Journal - 26-Sep-2014

The U.S. government will pay the Navajo Nation $554 million to settle long-standing claims that it mismanaged funds and natural resources on the tribe's reservation for years....

The Wall Street Journal - 26-Sep-2014

Connecticut gubernatorial candidate Joe Visconti opposes the state's new gun restrictions, and he has an online commercial that shows him riding in a 1974 Pontiac convertible with rifles fixed to the rear fenders. ...

The Wall Street Journal - 26-Sep-2014

The U.S. and Arab allies launched a second major wave of airstrikes in Syria targeting mobile oil refineries controlled by Islamic State, the Pentagon said....

0,3,4,5,6,7,8

Villich Login
 
Username:

Password:
Remember login